Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
- PMID: 33765410
- PMCID: PMC7984864
- DOI: 10.1016/S0140-6736(21)00468-2
Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
Comment on
-
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Lancet. 2021. PMID: 33306989 Free PMC article. Clinical Trial.
Similar articles
-
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.Lancet Infect Dis. 2022 Jun;22(6):791-801. doi: 10.1016/S1473-3099(22)00140-2. Epub 2022 Apr 1. Lancet Infect Dis. 2022. PMID: 35366959 Free PMC article.
-
In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.Ann Intern Med. 2021 Mar;174(3):JC29. doi: 10.7326/ACPJ202103160-029. Epub 2021 Mar 2. Ann Intern Med. 2021. PMID: 33646835
-
Oxford COVID-vaccine paper highlights lingering unknowns about results.Nature. 2020 Dec;588(7838):378-379. doi: 10.1038/d41586-020-03504-w. Nature. 2020. PMID: 33293710 No abstract available.
-
Role of COVID-19 Vaccines in SARS-CoV-2 Variants.Front Immunol. 2022 May 20;13:898192. doi: 10.3389/fimmu.2022.898192. eCollection 2022. Front Immunol. 2022. PMID: 35669787 Free PMC article. Review.
-
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27. Clin Microbiol Infect. 2022. PMID: 34715347 Free PMC article. Review.
Cited by
-
[Impact of spike genetic variants in vaccines against SARS-CoV-2].Vacunas. 2021 May-Aug;22(2):59-61. doi: 10.1016/j.vacun.2021.04.001. Epub 2021 Apr 9. Vacunas. 2021. PMID: 33867900 Free PMC article. Spanish. No abstract available.
-
Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up.Viruses. 2022 Feb 2;14(2):312. doi: 10.3390/v14020312. Viruses. 2022. PMID: 35215903 Free PMC article.
-
Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 Replication by Hypertonic Saline Solution in Lung and Kidney Epithelial Cells.ACS Pharmacol Transl Sci. 2021 Sep 3;4(5):1514-1527. doi: 10.1021/acsptsci.1c00080. eCollection 2021 Oct 8. ACS Pharmacol Transl Sci. 2021. PMID: 34651104 Free PMC article.
-
Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine.Front Immunol. 2022 Aug 15;13:952229. doi: 10.3389/fimmu.2022.952229. eCollection 2022. Front Immunol. 2022. PMID: 36045689 Free PMC article. Review.
-
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.Signal Transduct Target Ther. 2022 Feb 25;7(1):61. doi: 10.1038/s41392-022-00920-4. Signal Transduct Target Ther. 2022. PMID: 35217639 Free PMC article.
References
-
- Huang B, Dai L, Wang H, et al. Neutralization of SARS-CoV-2 VOC 501Y.V2 by human antisera elicited by both inactivated BBIBP-CorV and recombinant dimeric RBD ZF2001 vaccines. bioRxiv. 2021 doi: 10.1101/2021.02.01.429069. published online Feb 2. (preprint). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous